Skip to main content

Table 5 Median coefficient of determination R2of the correlation between relative bioZR + Xchanges at 8 kHz and UFV according to comorbidities that can influence the thoracic congestion

From: Towards personalized fluid monitoring in haemodialysis patients: thoracic bioimpedance signal shows strong correlation with fluid changes, a cohort study

Comorbidity

Median R2

no COPD and no heart failurea (n = 33)

0.981 [0.859–0.935]

COPD or heart failure (n = 23)

0.982 [0.935–0.994]

heart failure (n = 13)

0.979 [0.887–0.992]

no heart failure (n = 41)

0.982 [0.914–0.993]

COPD (n = 6)

0.988 [0.973–0.997]

no COPD (n = 48)

0.980 [0.858–0.993]

  1. bioZR resistance; bioZX reactance; COPD chronic obstructive pulmonary disease
  2. a Heart failure includes: dilated cardiomyopathy, systolic dysfunction, diastolic dysfunction, left or right sided heart failure